Hematologic Malignancies
📧 Sign up to get email alerts when something new happens for Hematologic Malignancies.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-01-24Clinical Trial Update: PEA for the Relief of Chemotherapy-Induced Peripheral Neuropathy [Phase 2]
Phase 2 trial evaluating palmitoylethanolamide (PEA) for relief of chemotherapy-induced peripheral neuropathy; study is active-not-recruitin…
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: Digital Meditation for Postoperative Pain Control After Abdominal Surgery for Cancer [EARLY_Phase 1]
Update on an early Phase 1 trial evaluating digital meditation to help manage postoperative pain after abdominal cancer surgery.
-
CLINICAL_TRIALS trial_result · 2025-01-07Clinical Trial Update: Adoptive Immunotherapy With Activated Marrow Infiltrating Lymphocytes and Cyclophosphamide Graft-Versus-Host Disease Prophylaxis in Patients With Relapse of Hematologic Malignancies After Allogeneic Hematopoietic Cell Transplantation [Phase 1]
Phase 1 trial update on adoptive immunotherapy using activated marrow-infiltrating lymphocytes with cyclophosphamide for GVHD prophylaxis in…
-
CLINICAL_TRIALS trial_result · 2024-12-04Clinical Trial Update: Evaluation of ClearLLab LS Screening Panel
Beckman Coulter completed a clinical trial evaluating the ClearLLab LS Screening Panel for hematologic malignancies.
-
CLINICAL_TRIALS trial_result · 2024-12-03Clinical Trial Update: Lenalidomide and Ipilimumab After Stem Cell Transplant in Treating Patients With Hematologic or Lymphoid Malignancies [Phase 2]
This Phase 2 trial studied the combination of lenalidomide and ipilimumab after stem cell transplantation in patients with hematologic or ly…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-12-02Clinical Trial Update: Mindfulness and CBT for Sleep [NA]
A completed trial evaluating mindfulness and cognitive-behavioral therapy for sleep in patients with hematologic malignancies; results have …
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients [Phase 1]
Phase 1 study evaluating intravenous and oral isavuconazonium sulfate in pediatric patients with hematologic malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2024-11-14Clinical Trial Update: Improving Quality of Life in Frail, Older Patients with Hematological Cancer Through Geriatric Assessment and Treatment - a Pilot Study [NA]
Completed pilot study examining whether geriatric assessment-guided treatment can improve quality of life for frail, older patients with hem…
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: Nozin in Preventing Respiratory Viral Infections in Patients Undergoing Stem Cell Transplant, PREV-NOSE STUDY [Phase 1]
The PREV-NOSE Phase 1 trial evaluating Nozin to prevent respiratory viral infections in patients undergoing stem cell transplant was termina…
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: A Study Evaluating the Safety, Tolerability and Preliminary Efficacy of IBI322 in Subjects With Hematologic Malignancy [Phase 1]
Phase 1 study of IBI322 in patients with hematologic malignancies has completed, reporting on safety, tolerability and preliminary efficacy.
-
CLINICAL_TRIALS trial_result · 2024-10-09Clinical Trial Update: Targeting the IPA and Matching for the Non-Inherited Maternal Antigen for Haplo-Cord Transplantation [Phase 2]
Phase 2 trial update for IPA targeting and non-inherited maternal antigen matching in haplo-cord transplantation for hematologic malignancie…
-
CLINICAL_TRIALS trial_result · 2024-09-24Clinical Trial Update: Patient Registry in Patients Undergoing Contrast-Enhanced Harmonic Endoscopic Ultrasound Imaging
This is a Mayo Clinic-sponsored patient registry evaluating contrast-enhanced harmonic endoscopic ultrasound imaging. The study status is co…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: A Study to Compare Forms of Nemtabrutinib (MK-1026) in Healthy Adult Participants (MK-1026-007) [Phase 1]
A Phase 1 study comparing different forms of nemtabrutinib (MK-1026) in healthy adult participants has completed.
-
CLINICAL_TRIALS trial_result · 2024-08-19Clinical Trial Update: Monoclonal Gammopathy With Clinical Significance in Patients With and Without Haematological Malignancies in Finistère Between 2012 and 2017 (GammaClinik)
Completed clinical trial investigating monoclonal gammopathy with clinical significance in patients with and without hematologic malignancie…
-
CLINICAL_TRIALS trial_result · 2024-08-13Clinical Trial Update: Haplo-PBSC+Cord vs Haplo-PBSC+BM for Hematological Malignancies Undergoing Allo-HSCT [Phase 3]
A Phase 3 clinical trial comparing haploidentical peripheral blood stem cell plus cord blood versus haploidentical peripheral blood stem cel…
-
CLINICAL_TRIALS trial_result · 2024-07-30Clinical Trial Update: Positive Psychology Intervention In HSCT [NA]
Completed clinical trial evaluating a positive psychology intervention in hematopoietic stem cell transplant patients; results were posted o…
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: Leflunomide for the Treatment of Severe COVID-19 in Patients With a Concurrent Malignancy [Phase 1, Phase 2]
This document reports completion and results posting for a Phase 1/2 study evaluating leflunomide as a treatment for severe COVID-19 in pati…
-
CLINICAL_TRIALS trial_result · 2024-07-01Clinical Trial Update: Proof-of-Concept Trial of a Positive Psychology Intervention for Caregivers of Patients Undergoing HSCT [NA]
A completed proof-of-concept trial tested a positive psychology intervention for caregivers of patients undergoing hematopoietic stem cell t…
-
CLINICAL_TRIALS trial_result · 2024-06-18Clinical Trial Update: Testing AZD9291 as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes (MATCH-Subprotocol E) [Phase 2]
Phase 2 MATCH subprotocol evaluating AZD9291 (osimertinib) as a targeted treatment for cancers with EGFR genetic changes; the trial is curre…
-
CLINICAL_TRIALS trial_result · 2024-05-10Clinical Trial Update: A Trial of PF-07901800 (TTI-621) for Patients With Hematologic Malignancies and Selected Solid Tumors [Phase 1]
Pfizer's Phase 1 trial of PF-07901800 (TTI-621) in patients with hematologic malignancies and selected solid tumors was terminated, with res…
-
CLINICAL_TRIALS trial_result · 2024-05-10Clinical Trial Update: Outcomes of Critically Ill Patients With Hematologic Malignancies
Clinical trial update summarizing the outcomes of critically ill patients with hematologic malignancies; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2024-03-19Clinical Trial Update: Durvalumab and Tremelimumab for Pediatric Malignancies [Phase 1, Phase 2]
Phase 1/2 trial evaluating durvalumab and tremelimumab in pediatric malignancies has results posted; the study is currently active but not r…
-
CLINICAL_TRIALS trial_result · 2024-03-12Clinical Trial Update: PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN [Phase 2]
Phase II, single-center randomized open-label trial evaluating the impact of serial procalcitonin measurements in patients with hematologic …
-
CLINICAL_TRIALS trial_result · 2024-01-24Clinical Trial Update: Clinical Trial for Non-inferiority and Safety of Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate in Patients With Hematologic Malignancies Who Require Prophylactic Hepatitis B Antiviral Treatment [Phase 4]
Phase 4 trial evaluating non-inferiority and safety of Tenofovir Alafenamide vs Tenofovir Disoproxil Fumarate in patients with hematologic m…
-
CLINICAL_TRIALS trial_result · 2023-07-17Clinical Trial Update: Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant [Phase 3]
Phase 3 trial evaluating whether Lactobacillus plantarum can prevent acute graft-versus-host disease in children undergoing donor stem cell …